Clinical Trials List
2021-01-01 - 2029-10-31
Phase III
Recruiting7
ICD-10C67.0
Malignant neoplasm of trigone of bladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.0
Malignant neoplasm of trigone of urinary bladder
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yeong-Shiau Pu 無
- JIAN-HUA HONG 無
- Yu-Chieh Tsai 無
- Chia-Hsien Chen 無
- 王中傑 無
- YI-KAI CHANG 無
- 曾啟新 無
- FU-JEN HSUEH 無
- CHING-CHU LU 無
- YU-CHUAN LU 無
- SHUO-MENG WANG 無
- Ying-Chun Shen 無
- - - 無
- CHUNG-HSIN CHEN 無
- PO-MING CHOW 無
- JHE-CYUAN GUO 無
- 呂紹綸 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hong-Cheng Gan Division of Hematology & Oncology
- 吳燿宇 Division of Radiation Therapy
- 沈鼎文 Division of Radiology
- Kai-Jie Yu Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 詹頂立 Division of Radiation Therapy
- 吳俊德 Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Yuan-Cheng Chu N/A
- 張境夫 Division of Hematology & Oncology
- 黃亮鋼 N/A
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 無
- Han Chang 無
- Chi-Ping Huang 無
- 賴宥良 無
- Chao-Hsiang Chang 無
- Yu-Cheng Kuo 無
- Po-Jen Hsiao 無
- Yu-De Wang 無
- Wei-Ching Lin 無
- Ji-An Liang 無
- Su-Peng Yeh 無
- 謝德鈞 無
- 陳冠亨 無
- Ching-Chan Lin 無
- Yi-Huei Chang 無
- Chi-Rei Yang 無
- Po-Fan Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖博崎 Division of Urology
- Jian-Ri Li Division of Urology
- 張瓈文 Division of Urology
- 游惟強 N/A
- 盧嘉文 N/A
- JU-CHUAN HU Division of Urology
- 王樹吉 Division of Urology
- 洪晟鈞 Division of Urology
- Chuan-Shu Chen Division of Urology
- 熊小澐 N/A
- Shian-Shiang Wang Division of Urology
- Chia-Yen Lin Division of Urology
- Cheng-Che Chen Division of Urology
- 裘坤元 Division of Urology
- 賴谷順 Division of Urology
- 林雁婷 Division of Radiology
- 梅承恩 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kwang-Yu Chang Division of Hematology & Oncology
- Che-Yuan Hu Division of Hematology & Oncology
- Kuan-Yu Wu Division of Hematology & Oncology
- Liu Yi-Sheng Division of Radiology
- 薛尉廷 Division of Radiation Therapy
- Jiann-Hui Ou Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李政學 無
- Hung-Lung Ke Division of Urology
- Tsung-Yi Huang 無
- Jeng-Shiun Du Division of Hematology & Oncology
- Chih-Jen Huang Division of Radiation Therapy
- Ching-Chia Li Division of Urology
- 張顥瀚 Division of Urology
- Tsu-Ming Chien Division of Urology
- 阮雍順 Division of Urology
- 黃俊農 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
550 participants
